A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
Oral phenylephrine, a common nasal-congestion ingredient in over-the-counter drugs, shouldn't be used in monograph drug products, the Food and Drug Administration is proposing. The agency said a ...
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...
Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...
The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...
The FDA proposed discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed, because it 'is not ...
It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.
The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...